-
Health Commission: The recent outbreak in Fujian has been basically effectively controlled
Time of Update: 2021-10-09
The spokesperson of the National Health Commission Mi Feng said at the meeting that the recent epidemic in Fujian has basically been effectively controlled, and the results of prevention and control must be consolidated to prevent the epidemic from rebounding .
-
New crown survivors now have long-term sequelae: abnormal breathing, pain, etc.
Time of Update: 2021-10-09
Lianhe Zaobao The study reported that the most common sequelae of the survivors include breathing problems, fatigue, pain and anxiety; women and those who have been hospitalized due to the epidemic are more likely to have sequelae .
-
Health Commission: 26 new confirmed cases on the 5th, including 2 from the local area
Time of Update: 2021-10-09
As of 24:00 on October 5, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 838 confirmed cases (including 2 severe cases), a total of 90,836 cured and discharged cases, and a total of 4,636 deaths.
-
Why is a million-dollar anti-cancer drug so expensive?
Time of Update: 2021-10-09
According to the president of Fosun Kate, the manufacturer of the drug, domestic CAR-T cell therapy drugs are produced by the company based on the technology introduced by the United States kite company.
So, is there any hope of reducing the price of domestic CAR-T therapy?
-
World Heart Day talks about "salt". How can salt be reduced scientifically?
Time of Update: 2021-10-09
Feng Kaili, a doctoral student at the Peking Union Medical College School of Nutrition and Epidemiology of cardiovascular disease, told the Science and Technology Daily that some existing studies have shown the side effects of salt reduction, but these studies do not deny the necessity of salt reduction .
-
Anti-coronavirus oral drug monabiravir significantly reduces the risk of hospitalization or death
Time of Update: 2021-10-09
The results showed that the rate of hospitalization or death of patients taking monabigravir within 29 days was about 50% lower than that of the placebo control group.
-
Cutting-edge research: antihypertensive drugs in the context of new coronavirus pneumonia
Time of Update: 2021-10-09
1007/s11684-020-0800-y WeChat link: click here to read the WeChat articleClick here to read the WeChat articleClick here to read the WeChat article Introduction to Xu Jiuyang of Tsinghua University School of Medicine, Huang Chaolin of Wuhan Jinyintan Hospital, Cao Bin and Wang Chen of China-Japan Friendship Hospital, etc.
-
In the second half of the year, the chairman of more than 8 pharmaceutical companies resigned!
Time of Update: 2021-10-09
Yuexin Health On September 28, Yuexin Health issued an announcement stating that the company’s board of directors had recently received an application from the company’s chairman and president, Mr.
-
Message from Zhong Nanshan to the National Center for Respiratory Medicine: Strengthening Research and Transformation
Time of Update: 2021-10-09
" Zhong Nanshan said that the Guangzhou Laboratory and the Clinical Base of the National Respiratory Medicine Center of the First Affiliated Hospital of Guangzhou Medical University are engaged in research transformation, severe treatment, early prevention and early treatment.
-
The fifth domestic PD-L1 has been declared for listing, and market competition may usher in new changes
Time of Update: 2021-10-09
In China, no domestically-produced drug for PD-L1 monoclonal antibody has been approved yet, and those that are making rapid progress are still in the stage of submitting applications for marketing .
-
Deeply cultivate investment promotion and follow-up services, Guangxi promotes the leapfrog development of biomedicine
Time of Update: 2021-10-09
. In order to better develop biomedicine, Guangxi is improving the development environment of biomedical companies through a series of policies and measures such as talent introduction, capital investment, technological research and development, and market access, and attracting and supporting the development of biomedical companies in Guangxi .
-
Harbin disease control experts analyze the characteristics of this round of epidemic
Time of Update: 2021-10-09
Confirmed case 53: A confirmed case of new coronary pneumonia (common type), currently living in Chunlin Garden of Xinglong Forestry Bureau, Bayan County .
Confirmed case 54: A confirmed case of new coronary pneumonia (common type), currently living in Fuminjiayuan, Xinglong Forestry Bureau, Bayan County .
-
Some areas of our country have begun to strengthen immunization for key populations
Time of Update: 2021-10-09
Regarding the question of whether it is necessary to vaccinate the new coronavirus vaccine, Wang Huaqing, chief expert of the immunization program of the China Centers for Disease Control and Prevention, made an explanation at a press conference of the Joint Prevention and Control Mechanism of the State Council on the 29th .
-
With the rapid development of the Internet, many pharmacies are launching online drug sales business
Time of Update: 2021-10-09
The industry believes that with the development of national online shopping habits and the improvement of the convenience of logistics and distribution, coupled with the increase in the supply of medicines on the pharmaceutical e-commerce platform, some of the non-urgently needed medical supplies demand of netizens has shifted to the online .
-
A total of 233,136,147 confirmed cases of new crowns worldwide
Time of Update: 2021-10-09
WHO: The global cumulative number of confirmed cases of new crown reached 233,136,147 WHO: The global cumulative number of confirmed cases of new crown reached 233,136,147 WHO: The
-
Heilongjiang Working Group on Joint Prevention and Control of the State Council: The epidemic is in a stalemate
Time of Update: 2021-10-09
Experts from the Heilongjiang Working Group on Joint Prevention and Control of the State Council: The epidemic situation is in a state of stalemate and close contact management needs to be
-
CPhI & P-MEC China 2021 invites you to build a pharmaceutical innovation ecosystem
Time of Update: 2021-10-09
At that time, the event week will provide high-level and in-depth social feasts for industry insiders before, during and after the exhibition, provide effective support for enterprises to optimize strategic deployment, explore international business opportunities, and jointly build a pharmaceutical R&D innovation ecosystem .
-
How to prevent and control the epidemic as the holidays are coming?
Time of Update: 2021-10-09
Hou Zhengang, the first-level inspector of the Marketing Management Department of the Ministry of Culture and Tourism, said that the cultural and tourism industry must strictly implement the requirements of "limited, appointment, and peak shifting" in tourist attractions, and strictly implement epidemic prevention and control management in all aspects of tourism, public libraries, theaters, and theaters.
-
A total of 234,809,103 confirmed cases of new crowns worldwide
Time of Update: 2021-10-09
WHO: The global cumulative number of confirmed cases of new crown reached 234,809,103 WHO: The global cumulative number of confirmed cases of new crown reaches 234,809,103 WHO: The global cumulative number of confirmed cases of new crown reaches 234,809,103 Xinhua News Agency, Geneva, October 4 (Reporter Liu Qu) The latest data released by the World Health Organization on the 4th showed that the total number of confirmed cases of new crown in the world reached 234,809,103 .
-
Why do we need to carry out booster immunization for key populations?
Time of Update: 2021-10-09
Detailed explanation by experts in disease control Why do we need to carry out booster immunization for key populations?
The relevant unit team in Guangdong has done research and can see that the vaccine protects the pneumonia caused by the new crown.
